DCM
AUTL
DAFNA Capital Management’s Autolus Therapeutics AUTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $970K | Sell |
425,616
-161,051
| -27% | -$367K | 0.27% | 59 |
|
|
2025
Q1 | $909K | Hold |
586,667
| – | – | 0.26% | 61 |
|
|
2024
Q4 | $1.38M | Buy |
586,667
+100,000
| +21% | +$235K | 0.35% | 50 |
|
|
2024
Q3 | $1.77M | Buy |
486,667
+140,000
| +40% | +$508K | 0.42% | 49 |
|
|
2024
Q2 | $1.21M | Buy |
346,667
+130,000
| +60% | +$452K | 0.29% | 59 |
|
|
2024
Q1 | $1.38M | Buy |
216,667
+25,597
| +13% | +$163K | 0.31% | 55 |
|
|
2023
Q4 | $1.23M | Sell |
191,070
-737,183
| -79% | -$4.75M | 0.29% | 57 |
|
|
2023
Q3 | $2.16M | Sell |
928,253
-2,141
| -0.2% | -$4.99K | 0.67% | 38 |
|
|
2023
Q2 | $2.21M | Sell |
930,394
-245,756
| -21% | -$585K | 0.61% | 39 |
|
|
2023
Q1 | $2.16M | Hold |
1,176,150
| – | – | 0.65% | 37 |
|
|
2022
Q4 | $2.23M | Buy |
1,176,150
+680,000
| +137% | +$1.29M | 0.63% | 43 |
|
|
2022
Q3 | $1.06M | Hold |
496,150
| – | – | 0.29% | 53 |
|
|
2022
Q2 | $1.4M | Hold |
496,150
| – | – | 0.38% | 53 |
|
|
2022
Q1 | $2.07M | Buy |
+496,150
| New | +$2.07M | 0.54% | 47 |
|
|
2020
Q3 | – | Sell |
-64,235
| Closed | -$1.03M | – | 81 |
|
|
2020
Q2 | $1.03M | Sell |
64,235
-155,565
| -71% | -$2.49M | 0.3% | 55 |
|
|
2020
Q1 | $1.32M | Buy |
219,800
+119,800
| +120% | +$718K | 0.55% | 40 |
|
|
2019
Q4 | $1.32M | Hold |
100,000
| – | – | 0.45% | 51 |
|
|
2019
Q3 | $1.24M | Hold |
100,000
| – | – | 0.47% | 54 |
|
|
2019
Q2 | $1.61M | Buy |
+100,000
| New | +$1.61M | 0.61% | 47 |
|